发明名称 New pyrrolopyrimidine compounds are epidermal growth factor receptor tyrosine kinase inhibitors useful for preventing or treating proliferative or inflammatory disease, where the disease is e.g. cancer, asthma, allergy and psoriasis
摘要 <p>Pyrrolopyrimidine compounds (I) and their stereoisomers, salts or metabolites, are new. Pyrrolopyrimidine compounds of formula (I) and their stereoisomers, salts or metabolites, are new. X, Y 1>a bond, -O-, -S-, -(C=O)-, -O(C=O)- or -(C=O)-O-; n : 0 or 1; R 1>, R 2>H, pyridyl, pyridyl substituted with F, Cl, Br, I or 1-4C-alkyl, phenyl, or phenyl substituted with carbamoyl-methoxy, carboxy-methoxy, benzyloxycarbonylmethoxy, 1-4C-alkoxycarbonyl-methoxy, phenyl, amino, 1-4C-alkanoylamino, 1-4C-alkylamino, N,N-di-1-4C-alkylamino, OH, 1-4C-alkanoyloxy, carboxyl, 1-4C-alkoxycarbonyl, carbamoyl, N-1-4C-alkyl-carbamoyl, N,N-di-1-4C-alkyl-carbamoyl, CN, or with nitro, N-benzyl-pyridinium-2-yl, naphthyl, 1-4C-alkoxycarbonyl, N-1-4C-alkyl-carbamoyl, N-N-di-1-4C-alkyl-carbamoyl, N-benzylcarbamoyl, formyl, 1-4C-alkanoyl, 1-4C-alkenyl, 1-4C-alkenyloxy, 1-4C-alkyl, 1-4C-alkyl substituted with F, Cl, Br, I, aminopiperazino, di-1-4C-alkylamino, phenylamino, substituted phenyl amino, or 1-4C-alkyl-S(O) z-; z : 0-2; R 3>H, 1-4C-alkyl, 1-4C-alkoxycarbonyl, carbamoyl, N-1-4C-carbamoyl or N,N-di-1-4C-alkyl-carbamoyl; and R 4>H, F, Cl, Br, I, 1-4C-alkyl, OH, 1-4C-alkanoyloxy, 1-4C-alkoxy, carboxyl, 1-4C-alkoxycarbonyl, carbamoyl, N-1-4C-carbamoyl or N,N-di-1-4C-alkyl-carbamoyl, cyano, amino, 1-4C-alkanoylamino, 1-4C-alkylamino, N,N-di-1-4C-alkylamino or trifluoromethyl (all are 1-3 times substituted). Where at least one of the group X or Y 1>is not a bond. An independent claim is included for a pharmaceutical composition comprising (I), optionally an auxiliary material and/or carrier materials. [Image] ACTIVITY : Cytostatic; Antiinflammatory; Antiasthmatic; Antiallergic; Ophthalmological; Dermatological; Antiarthritic; Osteopathic; Gastrointestinal-Gen.; Antibacterial; Immunosuppressive; Antidiabetic; Hemostatic; Neuroprotective; Muscular-Gen.; Antipsoriatic; Nephrotropic; Respiratory-Gen.; Anabolic; Anorectic; Cardiant. MECHANISM OF ACTION : Epidermal growth factor receptor tyrosine kinase inhibitor.</p>
申请公布号 DE102008021699(A1) 申请公布日期 2009.10.29
申请号 DE20081021699 申请日期 2008.04.25
申请人 SCHEBO BIOTECH AG 发明人 SCHEEFERS, HANS
分类号 C07D487/04;A61K31/506 主分类号 C07D487/04
代理机构 代理人
主权项
地址